Ikarian Capital »

Corcept Therapeutics Incorporated shares owned by Ikarian Capital

Quarter-by-quarter ownership of Corcept Therapeutics Incorporated (CORT) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Corcept Therapeutics Incorporated

Tip: Access up to 7 years of quarterly data

All positions including Corcept Therapeutics Incorporated held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corcept Therapeutics Incorporated by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $32M 1.3M 25.19
2023-12-31 $18M 543k 32.48

More positions owned by Ikarian Capital

Krystal Biotech Put Option (KRYS)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Alnylam Pharmaceuticals (ALNY)
Crinetics Pharmaceuticals In (CRNX)
Sarepta Therapeutics (SRPT)
Corcept Therapeutics Incorporated Put Option (CORT)
Tarsus Pharmaceuticals (TARS)
Disc Medicine (IRON)
Soleno Therapeutics (SLNO)
Corbus Pharmaceuticals Hldgs Com New (CRBP)
Astrazeneca Sponsored Adr Call Option (AZN)
Bridgebio Pharma (BBIO)
Eyepoint Pharmaceuticals Com New (EYPT)
Biomea Fusion Put Option (BMEA)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Corcept Therapeutics Incorporated

BlackRock
Vanguard Group
Ingalls & Snyder
Parallel Advisors
Dimensional Fund Advisors
Geode Capital Management
First Trust Advisors
Btim
Federated Investors
Arrowstreet Capital, Limited Partnership
Morgan Stanley
Man Group
Susquehanna International
Ikarian Capital
Millennium Management

View all funds holding Corcept Therapeutics Incorporated